Clinical Trial

Feasibility and Safety of Early Mobilization and Rehabilitation in Intensive Care Unit Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 23, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.
Summary
Intensive Care Unit Acquired Weakness (ICU-AW) is a common complication of critical illnesses, occurring in approximately 50% of ICU patients and is strongly associated with increased morbidity, physical impairments, and both short- and long-term mortality. The main characteristics of ICU-AW are symmetrical generalised muscle weakness affecting both respiratory and limb muscles; however, the clinical phenotype may differ depending on age, disease burden, length of ICU stay, and mechanical ventilation duration. The objective of the present study is to evaluate the feasibility achieved and the safety outcomes reported in a cohort of critically ill patients who undergo early mobilisation and rehabilitation in intensive care units. This research is a multicentre prospective cohort study.
Trial Details
NCT Number NCT06653998
Lead Sponsor Claudia Aristizábal
Conditions Intensive Care Unit Acquired Weakness, Intensive Care Unit Patients
Enrollment 220 participants
Start Date 2024-05-10
Primary Completion 2025-03 (estimated)
Study Completion 2025-04 (estimated)
Updated on ClinicalTrials.gov 2024-10-23